Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MITCHELL E GEFFNER

Allopathic & Osteopathic Physicians Pediatrics Pediatric Endocrinology

NPI
1043302391
CMS profile
46689
Location
LOS ANGELES, CA

General Payments · PY2018–2024

$172,105.33

  • Reported across 191 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$30,510.00

27 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Neurocrine BioSciences, Inc. $11,180.53 16
Eton Pharmaceuticals, Inc. $10,091.40 1
Ascendis Pharma Inc $4,317.50 2
TOLMAR, INC. $2,292.11 4
PFIZER INC. $1,850.00 2
Theratechnologies Inc. $750.00 1
Novo Nordisk AS $28.46 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $53,783.23 51
PY2019 $20,892.78 36
PY2020 $15,286.51 11
PY2021 $8,901.27 5
PY2022 $10,783.11 29
PY2023 $31,948.43 32
PY2024 $30,510.00 27

Payment records · PY2024 (27)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Ascendis Pharma Inc $3,532.50 01/05/2024 Consulting Fee Undisputed 01/23/2026 1133843264 CMS
Ascendis Pharma Inc $785.00 04/03/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1133844268 CMS
Eton Pharmaceuticals, Inc. $10,091.40 01/11/2024 Consulting Fee Undisputed 01/23/2026 1108021428 CMS
Neurocrine Biosciences, Inc. $74.07 05/03/2024 Food and Beverage Undisputed 01/23/2026 1150813064 CMS
Neurocrine Biosciences, Inc. $673.95 09/01/2024 Travel and Lodging Undisputed 01/23/2026 1150810011 CMS
Neurocrine Biosciences, Inc. $139.98 09/06/2024 Food and Beverage Undisputed 01/23/2026 1150807197 CMS
Neurocrine Biosciences, Inc. $118.94 09/06/2024 Travel and Lodging Undisputed 01/23/2026 1150849828 CMS
Neurocrine Biosciences, Inc. $75.00 09/07/2024 Food and Beverage Undisputed 01/23/2026 1150813008 CMS
Neurocrine Biosciences, Inc. $50.00 09/07/2024 Food and Beverage Undisputed 01/23/2026 1150814042 CMS
Neurocrine Biosciences, Inc. $50.00 09/07/2024 Food and Beverage Undisputed 01/23/2026 1150814048 CMS
Neurocrine Biosciences, Inc. $28.00 09/07/2024 Food and Beverage Undisputed 01/23/2026 1150831144 CMS
Neurocrine Biosciences, Inc. $215.46 09/07/2024 Travel and Lodging Undisputed 01/23/2026 1150834978 CMS
Neurocrine Biosciences, Inc. $25.00 09/07/2024 Food and Beverage Undisputed 01/23/2026 1150839828 CMS
Neurocrine Biosciences, Inc. $68.94 09/07/2024 Travel and Lodging Undisputed 01/23/2026 1150858969 CMS
Neurocrine Biosciences, Inc. $7,000.00 09/16/2024 Consulting Fee Undisputed 01/23/2026 1150806965 CMS
Neurocrine Biosciences, Inc. $120.00 09/16/2024 Travel and Lodging Undisputed 01/23/2026 1150849780 CMS
Neurocrine Biosciences, Inc. $16.40 09/16/2024 Food and Beverage Undisputed 01/23/2026 1150870965 CMS
Neurocrine Biosciences, Inc. $24.79 09/16/2024 Travel and Lodging Undisputed 01/23/2026 1150880679 CMS
Neurocrine Biosciences, Inc. $2,500.00 12/19/2024 Consulting Fee Undisputed 01/23/2026 1150866763 CMS
Novo Nordisk Inc $28.46 05/31/2024 Food and Beverage Undisputed 01/23/2026 1096983105 CMS
PFIZER INC. $1,480.00 06/24/2024 Consulting Fee Undisputed 01/23/2026 1131528396 CMS
PFIZER INC. $370.00 09/09/2024 Consulting Fee Undisputed 01/23/2026 1131897945 CMS
Theratechnologies Inc. $750.00 02/01/2024 Consulting Fee Undisputed 01/23/2026 1092907218 CMS
Tolmar, Inc. $8.52 02/05/2024 Food and Beverage Undisputed 01/23/2026 1138711054 CMS
Tolmar, Inc. $29.12 03/20/2024 Food and Beverage Undisputed 01/23/2026 1138712168 CMS
Tolmar, Inc. $2,140.00 03/29/2024 Honoraria Undisputed 01/23/2026 1138700687 CMS
Tolmar, Inc. $114.47 05/22/2024 Food and Beverage Undisputed 01/23/2026 1138711052 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.